About
Martin Borch Jensen is a longevity and biotech scientist-operator best known as co-founder and chief scientific officer of Gordian Biotechnology, a company developing pooled in vivo screening for age-related disease therapeutics. He also founded and leads Norn Group, a nonprofit focused on advancing longevity research through grantmaking, talent development, and roadmapping. In parallel, he serves on the advisory board of the Amaranth Foundation and is active in the broader geroscience ecosystem.
Areas of interest
longevityaging biologybiotechin vivo therapeuticsgene therapycell therapyAI in drug discoveryLLM/agent tooling for life sciencesdeep techhealth techthesis-driven philanthropyantibody engineering